DICEMBRINI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.190
EU - Europa 4.536
AS - Asia 3.202
SA - Sud America 582
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 81
OC - Oceania 51
Totale 15.733
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.082
RU - Federazione Russa 1.568
PL - Polonia 943
SG - Singapore 924
IT - Italia 909
CN - Cina 730
HK - Hong Kong 515
BR - Brasile 452
VN - Vietnam 382
IE - Irlanda 351
KR - Corea 241
SE - Svezia 205
FR - Francia 134
FI - Finlandia 120
DE - Germania 109
IN - India 88
CA - Canada 63
JO - Giordania 54
BD - Bangladesh 53
AR - Argentina 51
AU - Australia 50
GB - Regno Unito 50
ID - Indonesia 44
TR - Turchia 37
UA - Ucraina 36
IQ - Iraq 29
JP - Giappone 28
EC - Ecuador 27
CI - Costa d'Avorio 26
CH - Svizzera 25
MX - Messico 22
NL - Olanda 20
ES - Italia 19
ZA - Sudafrica 19
CO - Colombia 14
PK - Pakistan 13
HU - Ungheria 12
MA - Marocco 9
PE - Perù 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
AZ - Azerbaigian 7
EG - Egitto 7
LT - Lituania 7
PY - Paraguay 7
UZ - Uzbekistan 7
DZ - Algeria 6
SA - Arabia Saudita 6
AL - Albania 5
JM - Giamaica 5
NG - Nigeria 5
PT - Portogallo 5
TN - Tunisia 5
KZ - Kazakistan 4
LV - Lettonia 4
MD - Moldavia 4
TH - Thailandia 4
UY - Uruguay 4
HN - Honduras 3
IL - Israele 3
PA - Panama 3
PH - Filippine 3
PR - Porto Rico 3
TW - Taiwan 3
BE - Belgio 2
BH - Bahrain 2
CR - Costa Rica 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MM - Myanmar 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
TT - Trinidad e Tobago 2
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GP - Guadalupe 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.644
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.433
Warsaw 943
Ashburn 872
Singapore 692
Fairfield 682
Hong Kong 438
Dublin 351
Woodbridge 313
Seattle 298
Chandler 277
Cambridge 274
Houston 257
Seoul 239
Wilmington 228
Beijing 202
San Jose 175
Milan 166
Lawrence 138
Ho Chi Minh City 136
Altamura 135
Los Angeles 116
Princeton 107
Florence 106
Ann Arbor 104
Hefei 103
Moscow 103
Hanoi 84
Buffalo 81
Lauterbourg 74
Dallas 65
The Dalles 65
Rome 59
Boston 56
Mumbai 52
New York 52
Melbourne 49
Kent 47
Medford 47
Helsinki 45
San Diego 44
Council Bluffs 36
São Paulo 36
Boardman 35
Munich 34
Paris 33
Shanghai 33
Clifton 29
Naples 28
Jacksonville 27
Abidjan 26
Tokyo 26
Falls Church 25
Jakarta 24
Bern 21
Dong Ket 18
Rio de Janeiro 18
Turku 18
Figino 17
Guangzhou 17
Montreal 17
Andover 16
Bologna 16
Phoenix 16
Miano 15
Orem 15
Redondo Beach 14
Baghdad 13
Frankfurt am Main 12
Izmir 12
Quito 12
Turin 12
Da Nang 11
Falkenstein 11
London 11
Bari 10
Chicago 10
Gyöngyös 10
Hillsboro 10
Norwalk 10
Shenzhen 10
Toronto 10
Biên Hòa 9
Charlotte 9
Dhaka 9
Porto Alegre 9
Ankara 8
Bengaluru 8
Fortaleza 8
Haiphong 8
Hải Dương 8
Johannesburg 8
Redwood City 8
San Francisco 8
Tianjin 8
Amman 7
Catania 7
Curitiba 7
Guarulhos 7
Manaus 7
Mexico City 7
Totale 10.632
Salva come PNG Salva come JPEG
Nome #
Adipokines as possible new predictors of cardiovascular diseases: a case control study. 350
3-iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse 336
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 322
“Persistente secrezione di Exendin-4, un agonista recettoriale del Glucagon-like peptide-1, mediante terapia genica mediata da Adeno-associated Viruses, su ghiandole salivari di roditori in due differenti modelli di obesità/diabete tipo 2” 304
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. 297
Psychopathology and continuous subcutaneous insulin infusion in type 1 diabetes 293
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. 243
The therapy of insulin resistance in other diseases besides type 2 diabetes. 241
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 228
Cardiovascular effects of basal insulins 228
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 214
Effect of dipeptidyl-peptidase 4 inhibitors on circulating oxidative stress biomarkers in patients with type 2 diabetes mellitus 212
Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies 210
Hormonal signaling in biology and medicine 206
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 194
Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes 192
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials 192
Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies 190
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 190
Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. 186
Fasting and post-prandial glucose and diabetic complication. A meta-analysis 182
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 180
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials 173
Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review 173
Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance. 170
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 170
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 167
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 166
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. 165
Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis 165
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 165
Dipeptidyl peptidase-4 inhibitors and bone fractures: A meta-analysis of randomized clinical trials 161
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) 160
Bone: incretin hormones perceiver or receiver? 160
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: A meta-analysis of randomized clinical trials 159
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) project 158
Deprescription in elderly patients with type 2 diabetes mellitus 158
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy. 157
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 156
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 155
Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge 155
Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study 155
Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies 154
Orthorexia nervosa and type 1 diabetes: results of a cross-sectional study 154
A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes 154
combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in type 1 diabetes: A randomized cross‐over trial 154
Orlistat and sibutramine beyond weight loss 153
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 152
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 152
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 151
Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists 150
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials 148
Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies 147
Safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of randomized clinical trials 146
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 146
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. 146
Use of ancient grains for the management of diabetes mellitus: A systematic review and meta-analysis 144
Drugs for type 2 diabetes: Role in the regulation of bone metabolism 143
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 143
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials 142
Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials 141
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism. 139
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 139
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials 139
Cigarette Smoking as a Predictor of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Genital Infections: A Retrospective Cohort Study 138
Predictors of efficacy of Sodium-GLucose Transporter-2 inhibitors and Glucagon-Like Peptide 1 receptor agonists: A retrospective cohort study 136
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials 135
Vitamin D therapy in adults with diabetes mellitus. 134
Plasma adiponectin and hyperglycaemia in diabetic patients 134
Measurement of body composition as a surrogate evaluation of energy balance in obese patients. 130
Correction to: Glucose control in diabetes during home confinement for the first pandemic wave of COVID‑19: a meta‑analysis of observational studies (Acta Diabetologica, (2021), 58, 12, (1603-1611), 10.1007/s00592-021-01754-2) 130
Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials 129
The impossible return to the Garden of Eden: The ORIGIN trial and the original sin of early insulin treatment of type 2 diabetes 128
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 126
Correction to: Orthorexia nervosa and type 1 diabetes: results of a cross‑sectional study (Acta Diabetologica, (2023), 60, 5, (681-686), 10.1007/s00592-023-02044-9) 124
Incretin-based therapies and cardiovascular risk 124
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 124
Is glucose control important for prevention of cardiovascular disease in diabetes? 123
Inflammation markers and metabolic characteristic of subjects with one-hour plasma glucose levels 121
Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue? 120
Is there a practical way of predicting therapeutic success in type 2 diabetes on the basis of psychological features? Development and validation of the Psychological Predictors of Therapeutic success in Diabetes (PPTD) questionnaire 119
Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials (Acta Diabetologica, (2017), 54, 1, (19-36), 10.1007/s00592-016-0892-7) 116
Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support 115
Diabetes as a risk factor for invasive meningococcal disease. A meta-analysis of observational studies 114
Lipids seasonal variability in type 2 diabetes. 114
Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. 114
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials 114
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project 110
Glucose-lowering therapy in patients undergoing percutaneous coronary intervention 109
Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials 106
Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion 105
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials 105
Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes. 101
Le modificazioni dello stile di vita: curarsi o essere curato? 95
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials. 94
Fournier's gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials 94
EFFECTS OF ANTIHYPERTENSIVE TREATMENTS ON INCIDENCE OF DIABETES: A CASE-CONTROL STUDY. 91
Sustained Exendin-4 secretion through gene therapy targeting salivary glands in Zucker fa/fa rats and high fat diet mice 84
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown 55
Validation of a New Test for Assessing the Quality of Life Perceived in Patients with Type 1 Diabetes 27
Totale 15.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022549 14 39 54 23 16 32 27 36 24 40 61 183
2022/20231.524 179 354 58 86 62 258 203 64 159 8 50 43
2023/2024569 24 61 98 28 34 48 19 103 13 55 66 20
2024/20254.264 147 425 340 618 1.161 622 92 278 211 110 130 130
2025/20265.057 489 697 421 466 619 185 538 245 293 276 168 660
2026/2027182 182 0 0 0 0 0 0 0 0 0 0 0
Totale 15.733